ask="0.2050"
ask_size="10000"
average_daily_volume="6161140"
bid="0.1850"
bid_size="600"
book_value="0.1040"
change="-0.0036"
change_from_200_day_moving_average="-0.0833"
change_from_50_day_moving_average="-0.0062"
change_from_52_week_high="-0.4492"
change_From_52_week_low="0.0357"
change_in_percent="-1.8519%"
close="0.1908"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6780"
ebitda="-16.86M"
eps_estimate_current_year="-0.5200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="0.5100"
ex_dividend_date="N/A"
float_shares="124109000"
high="0.2000"
high_52_weeks="0.6400"
last_trade_date="1/27/2017"
last_trade_price="0.1908"
last_trade_size="713"
last_trade_time="4:00pm"
low="0.1850"
low_52_weeks="0.1551"
market_capitalization="25.05M"
moving_average_200_day="0.2741"
moving_average_50_day="0.1970"
name="Immune Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="3.0000"
open="0.2000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-30.3982%"
percent_change_from_50_day_moving_average="-3.1325%"
percent_change_from_52_week_high="-70.1875%"
percent_change_from_52_week_low="+23.0174%"
previous_close="0.1944"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="0.3741"
price_per_book="1.8692"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="131291000"
short_ratio="0.9400"
stock_exchange="NCM"
symbol="IMNP"
volume="4869998"
weeks_range_52="0.1551 - 0.6400"
